Publication | Closed Access

Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice

Alzheimer's DiseaseAgingLipopolysaccharide-induced Cognitive DysfunctionMedicineDementiaCyclooxygenase InhibitorsNeuropharmacologyNeuroprotectionNeuroscienceModulatory RoleAging-associated DiseasePharmacology